Nanospectra Biosciences
Houston
About Nanospectra Biosciences
Nanospectra Biosciences is a medical device company, engages in developing and commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors. The company provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. It also offers research-use-only nanoparticles with specific optical characteristics. Nanospectra Biosciences was founded in 2002 and is based in Houston, Texas.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $16.7M
- Last round: Series Unknown (Mar 2023)
- Website: nanospectra.com
- Phone: 7134409349
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/nanospectra-biosciences-39021 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.